The Central Drugs Standard Control Organisation (CDSCO) is set to take strict action against Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup, after several children died from consuming the syrup.

The CDSCO will write to the Tamil Nadu Food and Drug Administration (FDA) to take stringent measures against the company.

“CDSCO to write to Tamil Nadu-FDA to take strictest action against ‘Coldrif’ Syrup Manufacturer Sresan Pharmaceuticals,” said the official sources.

The affected children are from Madhya Pradesh’s Chhindwara, Rajasthan, and Maharashtra, while states like Kerala and Telangana have issued public alerts banning the use of Coldrif syrup.

Another company supplying cough syrups in Madhya Pradesh, Nextro DS, whose sample results are still pending.

“The Nextro DS sy

See Full Page